Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaping THC and Nicotine Pharmacokinetics (V-PAX)
NCT02955329Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2019
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial (3 arms), sponsored by University of California, San Francisco. Primary endpoints: Mean Delivered and Retained Doses, Median Peak THC Concentration and 9 more. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT02955329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955329.